TrialYonsei medical journal2015

NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.

Soo Rim Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.